LH

Labcorp (LH)

Labcorp Holdings Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NYSE:LH

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/09/25	05:21	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:LH	Labcorp Holdings Inc
2024/09/25	05:16	PR Newswire (US)	Labcorp to Announce Third Quarter Financial Results on October 24, 2024	NYSE:LH	Labcorp Holdings Inc
2024/09/24	05:18	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:LH	Labcorp Holdings Inc
2024/09/19	05:05	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:LH	Labcorp Holdings Inc
2024/09/18	20:00	PR Newswire (US)	Ovia Health Expands Women's Health Offerings with Comprehensive Postpartum Experience	NYSE:LH	Labcorp Holdings Inc
2024/09/18	19:12	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NYSE:LH	Labcorp Holdings Inc
2024/09/17	07:35	PR Newswire (US)	LABCORP PRICES $650,000,000 IN 4.350% SENIOR NOTES DUE 2030, $500,000,000 IN 4.550% SENIOR NOTES DUE 2032 AND $850,000,000 IN 4.800% SENIOR NOTES DUE 2034	NYSE:LH	Labcorp Holdings Inc
2024/09/17	06:30	Edgar (US Regulatory)	Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses	NYSE:LH	Labcorp Holdings Inc
2024/09/16	21:21	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NYSE:LH	Labcorp Holdings Inc
2024/09/16	20:30	PR Newswire (US)	Labcorp Completes Acquisition of Select Assets of BioReference Health's Diagnostics Business from OPKO Health	NYSE:LH	Labcorp Holdings Inc
2024/09/04	05:09	PR Newswire (US)	Labcorp to Speak at the Baird 2024 Global Healthcare Conference	NYSE:LH	Labcorp Holdings Inc
2024/08/09	23:16	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:LH	Labcorp Holdings Inc
2024/08/05	20:00	PR Newswire (US)	Labcorp Finalizes Acquisition of Select Assets of Invitae	NYSE:LH	Labcorp Holdings Inc
2024/08/02	21:30	PR Newswire (US)	Labcorp Receives FDA De Novo Marketing Authorization for PGDx elio™ plasma focus Dx	NYSE:LH	Labcorp Holdings Inc
2024/08/01	19:57	PR Newswire (US)	Labcorp Announces 2024 Second Quarter Results	NYSE:LH	Labcorp Holdings Inc
2024/07/30	20:00	PR Newswire (US)	Labcorp Expands Collaboration with Ultima Genomics to Advance Whole Genome Sequencing Applications and Oncology Testing Capabilities	NYSE:LH	Labcorp Holdings Inc
2024/07/25	19:59	PR Newswire (US)	Labcorp Declares Quarterly Dividend	NYSE:LH	Labcorp Holdings Inc
2024/07/01	20:00	PR Newswire (US)	Labcorp to Announce Second Quarter Financial Results on August 1, 2024	NYSE:LH	Labcorp Holdings Inc
2024/06/17	21:00	PR Newswire (US)	Labcorp Launches Global Trial Connect to Accelerate Clinical Trials	NYSE:LH	Labcorp Holdings Inc
2024/06/10	21:52	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:LH	Labcorp Holdings Inc
2024/06/04	20:41	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:LH	Labcorp Holdings Inc
2024/06/04	06:23	Edgar (US Regulatory)	Form 15-12G - Securities registration termination [Section 12(g)]	NYSE:LH	Labcorp Holdings Inc
2024/06/03	20:00	PR Newswire (US)	Labcorp Announces New Strategic Service Offerings within Precision Oncology Portfolio	NYSE:LH	Labcorp Holdings Inc
2024/05/31	02:18	Edgar (US Regulatory)	Form SD - Specialized disclosure report	NYSE:LH	Labcorp Holdings Inc
2024/05/30	20:00	PR Newswire (US)	Labcorp to Present Multiple Abstracts across Precision Oncology at the 2024 ASCO Annual Meeting	NYSE:LH	Labcorp Holdings Inc
2024/05/28	20:04	Edgar (US Regulatory)	Form 8-K - Current report	NYSE:LH	Labcorp Holdings Inc
2024/05/28	19:59	PR Newswire (US)	Labcorp to Speak at the 44th Annual William Blair Growth Stock Conference	NYSE:LH	Labcorp Holdings Inc
2024/05/18	05:57	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NYSE:LH	Labcorp Holdings Inc
2024/05/18	05:45	Edgar (US Regulatory)	Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers	NYSE:LH	Labcorp Holdings Inc
2024/05/18	05:41	Edgar (US Regulatory)	Form POSASR - Post-effective Amendment to an automatic shelf registration statement	NYSE:LH	Labcorp Holdings Inc